Recent research shows that Janus kinase inhibitors may be effective therapy in treatment of axial spondyloarthritis. Have you tried them in your practice? Let us know what you think with our brief quiz!
Recent research shows that Janus kinase inhibitors may be effective therapy in treatment of axial spondyloarthritis. Have you tried them in your practice? Let us know what you think with our brief quiz!
There are several therapeutic alternatives and combinations available for inducing remission in ANCA vasculitis. Which of these is your preferred first-line agent?
There are several therapeutic alternatives and combinations available for inducing remission in ANCA vasculitis. Which of these is your preferred first-line agent?
Patients with lupus nephritis may need guidance in following a healthy diet to protect their kidneys. Do you refer patients for dietary advice? Take our poll to voice your opinion!
Patients with lupus nephritis may need guidance in following a healthy diet to protect their kidneys. Do you refer patients for dietary advice? Take our poll to voice your opinion!
In a recent study, the Systemic Immune‐Inflammation Index (SII) proved to be an effective additional indicator in Behçet disease (BD) analysis. Would you use this in determining disease severity with patients with BD?
In a recent study, the Systemic Immune‐Inflammation Index (SII) proved to be an effective additional indicator in Behçet disease (BD) analysis. Would you use this in determining disease severity with patients with BD?
Inflammatory markers have proven useful in determining disease severity of patients with Behçet disease. Would you use the Systemic Immune‐Inflammation Index in your practice? Let us know with this quick poll!
Inflammatory markers have proven useful in determining disease severity of patients with Behçet disease. Would you use the Systemic Immune‐Inflammation Index in your practice? Let us know with this quick poll!
On the second day of Dermatology Week 2021, Dr Elizabeth Wallace introduced new, emerging therapies for the treatment of psoriasis. Read about her session highlights here.
On the second day of Dermatology Week 2021, Dr Elizabeth Wallace introduced new, emerging therapies for the treatment of psoriasis. Read about her session highlights here.
The US Food and Drug Administration has approved tofacitinib for the treatment of adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more tumor necrosis factor blockers.
The US Food and Drug Administration has approved tofacitinib for the treatment of adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more tumor necrosis factor blockers.
Leonard Calabrese, DO, discusses the symptoms and phenotypes of long COVID-19, its similarities to some presentations of systemic lupus erythematosus, and where rheumatologists fit into the treatment of these patients.
Leonard Calabrese, DO, discusses the symptoms and phenotypes of long COVID-19, its similarities to some presentations of systemic lupus erythematosus, and where rheumatologists fit into the treatment of these patients.